News, Culture & Society

Free-flu jabs will be offered to over-50s as NHS battles ‘twin threat’ of flu and coronavirus

People over the age of 50 will be entitled to a free flu vaccine from the beginning of next month as part of an expanded jab rollout in the face of the ‘twin threats’ of flu and coronavirus.

This latest age group can be vaccinated by their GP or pharmacist in England from December 1, the Department of Health and Social Care (DHSC) said.

Earlier this year the Government announced this winter would see the biggest flu vaccination programme in the UK’s history, with enough supply to vaccinate 30 million people throughout the flu season.

DHSC said flu vaccine uptake this year is higher in all vulnerable groups except pregnant women compared to the same time last year.

People over the age of 50 will be entitled to a free flu vaccine from the beginning of next month (file photo)

This latest age group can be vaccinated by their GP or pharmacist in England from December 1 (file photo)

England's deputy chief medical officer Professor Jonathan Van-Tam (pictured) urged all those eligible to get the jab

England’s deputy chief medical officer Professor Jonathan Van-Tam (pictured) urged all those eligible to get the jab

Health Secretary Matt Hancock said: ‘This winter is like no other, and we have to worry about the twin threats of flu and Covid-19.

‘Covid means getting a flu jab is more important than ever this year. So we are delivering the largest ever flu vaccination programme.’

England’s deputy chief medical officer Professor Jonathan Van-Tam urged all those eligible to get the jab.

He said: ‘Influenza vaccination is a critical tool this and every winter to prevent severe illnesses and potential hospitalisations for thousands of people.

‘I urge all those who are eligible for the flu vaccine, including the new group of 50 to 64-year-olds, to book their appointments as soon as they can.’

DHSC said GPs, trusts and pharmacists can order additional stock from the Government supply of more than seven million vaccines to vaccinate this latest group.

Dozens of mass vaccination centres will be set up within weeks with FIREMEN among workers retrained to inoculate millions of Britons against coronavirus, ministers plan

By James Robinson for Mail Online

Dozens of mass coronavirus vaccination sites will be set up across the country within weeks, while firefighters will be trained up to help deliver the inoculations, as part of plans by ministers to deliver millions of jabs in record time.

GP surgeries have been told to organise the initial wave, which will involve using community centres, village halls, and practices themselves to administer the jabs to care workers and the elderly as soon as next month.

The NHS is establishing a series of much larger venues to inject millions of others once those at the top of the priority list have had the jabs. 

Empty NHS Nightingale Hospitals and sports centres, including the Derby Arena, area are reportedly being lined up as possible venues.

Firefighters are also being encouraged  to join an army of 40,000 extra workers as NHS England aims to roll out up to one million jabs a day. 

Plans are being drawn up for mass vaccination sites across the country to deliver inoculations (pictured: stock image)

Plans are being drawn up for mass vaccination sites across the country to deliver inoculations (pictured: stock image)

Empty NHS Nightingale Hospitals and sports centres, including the Derby Arena (pictured), area are reportedly being lined up as possible venues

Empty NHS Nightingale Hospitals and sports centres, including the Derby Arena (pictured), area are reportedly being lined up as possible venues

Firefighters (pictured: Library image) are also being drafted in to join an army of 40,000 extra workers as NHS England aims to roll out up to one million jabs a day

Firefighters (pictured: Library image) are also being drafted in to join an army of 40,000 extra workers as NHS England aims to roll out up to one million jabs a day

According to documents seen by the Health Service Journal, the massive operation will start in the New Year.

It is likely to involve conference centres and drive-through sites such as those used by the Covid testing programme.

According to the Telegraph, Derby City Council has confirmed it is in talks with the Government over plans to use the Derby Arena as a vaccine site.

It could become one of the first sites where the vaccine is administered, as early as mid-December, the paper reports.

Every major city will get a dedicated mass vaccination centre, according to the Sun.

The paper reports that 50 sites are planned in sports arenas, town halls and NHS Nightingale hospitals , along with 1,000 smaller sites across England. 

Meanwhile, the NHS is said to be launching a major recruitment drive to hire up to 40,000 thousand staff to administer the Pfizer vaccine. 

Trained medics and nurses will be top of their wish list. 

But retired ­doctors and nurses and those who have first-aid skills from their jobs, including firefighters, police community support officers and members of the Armed Forces will also be targeted in the recruitment drive, the Sun reports.

The vaccination army, who will be trained, will be supported by an additional 30,000-strong team St John Ambulance volunteers, the paper adds.

The vaccination army, who will be trained, will be supported by an additional 30,000-strong team St John Ambulance volunteers (pictured: Library image), the paper adds

The vaccination army, who will be trained, will be supported by an additional 30,000-strong team St John Ambulance volunteers (pictured: Library image), the paper adds

Pfizer and BioNTech's final trial results showed that only eight people out more than 20,000 who got the vaccine caught coronavirus, compared to 162 who were given a fake jab

Pfizer and BioNTech’s final trial results showed that only eight people out more than 20,000 who got the vaccine caught coronavirus, compared to 162 who were given a fake jab 

Pfizer and BioNTech's final trial results showed that only eight people out more than 20,000 who got the vaccine caught coronavirus, compared to 162 who were given a fake jab

Pfizer and BioNTech’s final trial results showed that only eight people out more than 20,000 who got the vaccine caught coronavirus, compared to 162 who were given a fake jab 

Pfizer and BioNTech's vaccine works by using genetic material called RNA from the coronavirus to trick the body into making the 'spike' proteins that the virus uses to latch onto cells inside the body, and then training the immune systems to attack the spikes

Pfizer and BioNTech’s vaccine works by using genetic material called RNA from the coronavirus to trick the body into making the ‘spike’ proteins that the virus uses to latch onto cells inside the body, and then training the immune systems to attack the spikes

Scientists warn final results for Oxford vaccine won’t come for weeks

Oxford University’s Covid vaccine is unlikely to be used in the UK before Christmas as the scientists running the project said they don’t expect to have results to give regulators until December.

The researchers today published a study confirming that their vaccine candidate triggers an immune response in older people, who are most at risk of severe Covid-19, and that trials had not found any safety issues.

But the timescale for the jab, which Number 10 has ordered 100million doses of and is considered one of Britain’s greatest hopes for ending the epidemic, may stretch into early 2021 before people start getting injected.

Professor Andrew Pollard, director of the Oxford Vaccine Group, said today that he was ‘optimistic’ that the study would produce results showing how well it protects against Covid before Christmas. The following procedure for getting it licensed and then delivered to clinics, however, is ‘not under our control’ and could take weeks longer, he said, which would push the delivery into next year.

Scientists behind the project this morning published the results of an early trial of the jab, which found two doses created strong signs of immunity in 99 per cent of people across all age groups.

The second-phase study included 560 volunteers, most of whom were white and British, and showed that people across all age groups seemed to react equally well to the jab. It adds to data published in July suggesting it would work safely for under-55s. Studies of people with serious health conditions and other ethnicities are ongoing.

It marks another breakthrough in the race to develop a vaccine to prevent Covid, after jabs made by Moderna and Pfizer and BioNTech were both revealed to be around 95 per cent effective within the past week.

Oxford’s results are from an earlier stage of trials so cannot estimate how well the vaccine protects against Covid, but are still a positive step. The research showed people in all age groups developed neutralising antibodies – virus-destroying substances made by the immune system – within 28 days of their first dose of the vaccine, and these were boosted further after the second dose.

It showed that the vaccine caused more side effects than a fake jab but that these were ‘mild’ and more common in young people than older participants. Within the first week after having the injection more than eight out of 10 under-55s said their arm hurt and and they later experienced tiredness, muscle aches or headaches. Experts explained this might just be because younger people’s immune systems are more active and likely to over-react.

 

 

Britain’s drug regulator earlier this week revealed it is now waiting on Pfizer to send over the full results of its final Covid-19 vaccine trial after the pharmaceutical giant claimed it was safe, 95 per cent effective and works in older people who are most at risk of dying from the disease.

The US company, most famous for making Viagra, announced it would submit the necessary data to regulators in America and the UK ‘within days’, bolstering hopes that Britain could embark on its major Army-backed operation to vaccinate millions of people from as soon as December 1.

UK drug regulator the MHRA has been doing a ‘rolling review’ of the vaccine and could, as a result, complete the approval process within a matter of days of receiving the application from Pfizer and BioNTech, the German firm involved in making the jab.

Dr June Raine, the agency’s chief executive, said: ‘The results reported by Pfizer are very encouraging and add to their announcement from last week.

‘We look forward to receiving the full results of the trials as soon as possible, after which we will rigorously assess the evidence of safety and effectiveness of the vaccine.’

Britain has already pre-ordered 40million doses of the vaccine and could be set to get 10m of those next month, with the NHS gearing up start dishing it out within a fortnight.

Professor Stephen Powis, NHS England’s medical director, this week said the health service was ‘working incredibly hard’ to prepare.

Pfizer and BioNTech’s final trial results showed that only eight people out more than 20,000 who got the vaccine caught coronavirus, compared to 162 who were given a fake jab.

A total of 10 people got severe Covid-19, one of whom had been given the real vaccine.

An independent safety committee ‘has not reported any serious safety concerns related to the vaccine’ since the final stage trial began in July, Pfizer said.

Side effects were limited – the most common was fatigue, which 3.8 per cent of people got, and headaches (2 per cent).

The updated data from Pfizer and BioNTech should reassure critics but the Government still faces the mammoth task of transporting and storing the jab, which may need expensive specialist freezers and huge supplies of dry ice to keep it at the required -70°C (-94°F).  

The announcement is an improvement on Pfizer’s early estimate that the vaccine was 90 per cent effective, and comes just days after rival firm Moderna claimed its own jab was 94.5 per cent effective.

Unlike Pfizer’s jab, Moderna’s jab can be kept in normal fridges and freezers at between -20°C (-4°F) and 8°C (46°F). 

Health Secretary Matt Hancock earlier this week confirmed that Britain would get 5million doses of the jab starting in March 2021, if it’s approved by regulators.

The deal is expected to cost the UK between £24 ($32) and £28 ($37) per dose – while the US, which pre-ordered the jab months ago, will pay just $15 (£11.32) and is expected to get access next month if health chiefs approve the jab.

The UK is likely to pay around £15 per jab for the Pfizer vaccine.

Meanwhile, the home-grown vaccine being developed by Oxford University and Astrazenica could cost as little as £2.23. Results for the UK jab are expected in December.

Read more at DailyMail.co.uk


Comments are closed.